Delivery Order SPE2DR25D2217-SPE2DR26FC7FB
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $4,437.77. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order (4570164033) by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $8,022.58. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. The award reflects a routine pharmaceutical procurement supporting federal healthcare needs, with performance to be executed at AmerisourceBergen's facility in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 4, 2025, for the supply of Eliquis 5 mg tablets (60-count) at a firm fixed price of $2,907.19, with completion scheduled for December 5, 2025. This is a competitive, non-set-aside award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement that runs through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,382.14. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a contract value of $13,532.97. This firm fixed-price delivery order is set to be completed by December 19, 2025, and represents fulfillment under the company's broader pharmaceutical supply relationship with the federal government. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 9, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $21,441.91. This firm fixed-price delivery order, which is not set-aside, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,257.08 by the Defense Logistics Agency on December 5, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $9,813.10. This is a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2217Indefinite Delivery Contract
- SPE2DR25D2217-SPE2DR26FC7FBDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $4,146.14. The contract is a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded procurement that leverages AmerisourceBergen's established capabilities as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The parent IDC provides a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Eliquis delivery represents one of numerous drug procurement actions under this strategic vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/21/25 |